Sign in

Roivant Sciences Ltd.

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19
Total revenue 0.01 0.03 0.03 0.03 0.06 0.02 0.07 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Gross profit 0.01 0.03 0.03 0.03 0.05 0.02 0.07 0.00
Total operating expenses + 1.29 1.14 0.86 0.84 1.26 1.09 0.60 0.75
Operating income -1.29 -1.11 -0.82 -0.81 -1.21 -1.07 -0.53 -0.75
Non-operating income (net) 1.02 0.43 5.39 -0.08 0.29 0.17 -0.03 -0.06
Income before tax -0.26 -0.68 4.57 -0.88 -0.92 -0.90 -0.56 -0.81
Income tax expense 0.13 0.05 0.02 0.00 0.00 0.00 0.01 0.00
Net income -0.30 -0.17 4.35 -1.01 -0.85 -0.81 1.20 -1.04
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.03 0.02 0.00 0.02 0.03 0.02 0.01 0.00 0.01 0.02 0.01 0.01 0.02 0.01 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.02 0.02 0.00 0.02 0.02 0.01 0.01 0.00 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00
Total operating expenses + 0.36 0.34 0.31 0.29 0.29 0.28 0.35 0.35 0.29 -5.11 0.22 0.29 0.25 0.29 0.29 0.28 0.27 0.27 0.69 0.16 -0.04 0.26 0.16 0.12
Operating income -0.35 -0.34 -0.31 -0.28 -0.28 -0.27 -0.34 -0.34 -0.27 5.13 -0.21 -0.28 -0.23 -0.28 -0.28 -0.28 -0.27 -0.25 -0.68 -0.15 -0.54 -0.26 -0.16 -0.11
Non-operating income (net) 0.81 0.05 0.15 0.02 0.08 0.04 0.12 0.12 0.07 0.03 -0.03 -0.05 0.05 -0.10 -0.03 -0.07 -0.03 -0.06 0.46 0.05 -0.02 -0.02 0.10 0.11 0.00
Income before tax 0.45 -0.29 -0.16 -0.27 -0.20 -0.23 -0.22 -0.22 -0.19 5.15 -0.24 -0.33 -0.18 -0.38 -0.31 -0.35 -0.29 -0.31 -0.23 -0.10 -0.56 -0.28 -0.05 -0.01
Income tax expense 0.10 0.02 0.01 0.00 0.05 -0.03 0.01 0.01 -0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income 0.30 -0.27 -0.11 -0.22 -0.21 0.17 -0.23 -0.23 -0.15 5.10 -0.30 -0.29 -0.03 -0.35 -0.32 -0.35 -0.29 -0.28 -0.21 -0.08 -0.51 -0.26 -0.04 0.00
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19
Total cash and short-term investments + 4.30 4.89 6.54 1.68 2.07 2.21 2.19 0.85
Accounts receivable, net 0.79 0.08 0.04 0.01 0.01 0.02 0.01
Inventories 0.04 0.00 -0.02 0.06 0.00
Other current assets 0.08 0.11 0.07 0.08 0.08 0.04 0.02 0.32
Total current assets 5.17 5.00 6.73 1.80 2.15 2.19 2.22 1.19
Total non-current assets + 0.56 0.44 0.49 0.59 0.44 0.50 0.26 0.20
Total assets 5.73 5.44 7.22 2.39 2.59 2.69 2.48 1.39
Total current liabilities + 0.28 0.15 0.27 0.27 0.18 0.22 0.09 0.21
Total non-current liabilities + 0.15 0.10 0.51 0.51 0.34 0.31 0.28 0.24
Total liabilities 0.44 0.25 0.77 0.78 0.52 0.53 0.37 0.45
Total stockholders' equity + 4.53 4.69 5.97 1.16 1.66 1.90 2.03 0.94
Common shares outstanding 694 725 831 713 670 685 685 215
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 4.30 4.53 4.39 4.50 4.89 5.15 5.39 5.39 6.54 6.68 1.42 1.43 1.70 1.55 1.60 1.94 2.07 2.23 2.50 2.00 2.06 0.00 0.00 0.00 0.00
Accounts receivable, net 0.79 0.14 0.02 0.02 0.08 0.06 0.05 0.04 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.02
Inventories -0.19 0.03 0.04 0.01 0.00 0.00 0.00 0.06 0.07 -0.02 0.05 0.04 0.05
Other current assets 0.08 0.13 0.13 0.11 0.11 0.07 0.39 0.39 0.07 0.07 0.08 0.08 0.08 0.09 0.01 0.09 0.08 0.01 0.00 0.01 0.05 0.00
Total current assets 5.17 4.66 4.51 4.62 5.00 5.36 5.80 5.80 6.73 6.81 1.55 1.56 1.80 1.65 1.71 2.04 2.15 2.29 2.56 2.06 2.19 2.22
Total non-current assets + 0.56 0.57 0.55 0.42 0.44 0.43 0.40 0.40 0.49 0.51 0.51 0.58 0.59 0.56 0.50 0.56 0.44 0.51 0.55 0.40 0.40
Total assets 5.73 5.23 5.06 5.03 5.44 5.79 6.21 6.21 7.22 7.31 2.07 2.14 2.39 2.20 2.22 2.60 2.59 2.80 3.10 2.45 2.59
Total current liabilities + 0.28 0.15 0.13 0.11 0.15 0.14 0.56 0.56 0.27 0.24 0.27 0.25 0.27 0.24 0.23 0.33 0.18 0.16 0.30 0.21 0.22 0.09
Total non-current liabilities + 0.15 0.10 0.12 0.10 0.10 0.11 0.07 0.07 0.51 0.48 0.47 0.56 0.51 0.53 0.47 0.49 0.34 0.37 0.35 0.27 0.31
Total liabilities 0.44 0.25 0.26 0.22 0.25 0.26 0.63 0.63 0.77 0.73 0.74 0.80 0.78 0.78 0.70 0.82 0.55 0.55 0.65 0.47 0.53
Total stockholders' equity + 4.53 4.27 4.36 4.35 4.69 5.19 5.15 5.15 5.97 6.09 0.95 0.91 1.16 0.96 1.16 1.38 2.04 2.25 2.04 1.72 1.80
Common shares outstanding 812 697 681 680 707 723 735 735 803 844 770 759 743 713 700 696 693 687 685 685 685 685 685 685
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19
Operating cash flow + -0.75 -0.84 -0.77 -0.84 -0.68 -0.55 -0.76 -1.02
Cash flow from investing + -0.68 -1.77 5.20 -0.04 0.30 -0.03 1.69 -0.06
Cash flow from financing + 0.13 -1.22 0.42 0.50 0.31 0.46 0.22 0.77
Change in cash -1.30 -3.83 4.86 -0.39 -0.07 -0.13 1.15 -0.31
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.16 -0.20 -0.19 -0.20 -0.17 -0.21 -0.27 -0.27 -0.11 -0.21 -0.20 -0.25 -0.18 -0.22 -0.19 -0.25 -0.15 -0.27 -0.12 -0.14 -0.11 -0.24 -0.10 -0.11 -0.09
Cash flow from investing + 0.13 0.15 0.12 -1.09 1.07 0.45 -3.29 -3.29 0.01 5.23 -0.04 0.00 0.11 0.00 -0.15 -0.01 -0.01 -0.01 0.32 0.00 0.00 0.00 -0.03 -0.05
Cash flow from financing + -0.03 0.29 0.06 -0.19 -0.18 -0.27 -0.11 -0.11 -0.03 0.24 0.21 0.01 0.21 0.15 -0.01 0.14 0.00 -0.01 0.30 0.01 0.10 0.00 0.18 0.18 -1.10
Change in cash -0.06 0.24 0.00 -1.48 0.72 -0.03 -3.67 -3.67 -0.13 5.26 -0.03 -0.24 0.14 -0.07 -0.34 -0.12 -0.15 -0.28 0.50 -0.13 -0.01 -0.24 0.08 0.04 -1.23
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Operating Cashflow

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Dividend Payout

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Net Income

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Cashflow From Investment

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Capital Expenditures

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
about 2 months ago